1)cubosomes纳米立方液晶
1.Ocular pharmacokinetics of dexamethasone cubosomes in rabbit aqueous humor地塞米松纳米立方液晶眼用制剂家兔房水药代动力学
英文短句/例句
1.Ocular pharmacokinetics of dexamethasone cubosomes in rabbit aqueous humor地塞米松纳米立方液晶眼用制剂家兔房水药代动力学
2.Preparation of Cyclosporine A-loaded cubic nanoparticles and determination of encapsulation efficiency环孢素A立方晶纳米粒的制备及包封率的测定
3.Controllable Synthesis and Formation Mechanism of Spherical,Cubic and Hollow Cubic PbS Nanocrystals球状、立方状及空心立方状PbS纳米晶的控制合成及其形成机理
4.The Improvement of Controlled Chemical Synthesis of Sb Nanocrystal in Solution;Sb纳米晶的化学液相控制合成进展
5.The Research on Urinary Nanocrystallites and Its Effect Factor尿液中纳米微晶的检测及其影响因素
6.Recent advances in the liquid synthesis of group Ⅳ-Ⅵ semiconductor nanocrystalsⅣ-Ⅵ族半导体纳米晶的液相法合成
7.PREPARATION OF PE/CNTs SHISH-KEBAB STRUCTURES USING SOLUTION CRYSTALLIZATION溶液结晶制备聚乙烯/碳纳米管串晶结构
8.Studies on the Lyotropic Liquid Crystallines Formed by Lipids and Imidazolium-Type Ionic Liquids;类脂立方液晶及咪唑类离子液液晶的研究
9.Effect of Urinary pH Value on the Composition of Urinary Nanocrystals尿液pH变化与尿液中纳米微晶组分的关系
10.New Lyotropic Liquid Crystals with Ionic Liquids and Their Applications in Templating Synthesis of Nanomaterials;离子液体构建的新型溶致液晶及其在模板制备纳米材料方面的应用
11.Research on Preparation of Nano Oxide by Arc-discharge in Solution and In-situ Reaction of Pt Nanocrystals;溶液中放电制备纳米氧化物及铂纳米晶原位反应的研究
12.The Research on Functionalization and Liquid Crystals Composite of Multi-walled Carbon Nanotubes多壁碳纳米管功能化及其液晶纳米复合材料的研究
13.Research on nanocrystallites in urines of healthy persons and lithogenic patients by nanoparticle size analyzer纳米粒度仪研究尿石症患者和正常人尿液中的纳米微晶
14.Review Synthetic Methods of CdSe Semiconductor Nanocrystals;硒化镉（CdSe）半导体纳米晶制备方法评述
15.Synthesis of Tin Oxide Nanocrystals by Sol-Gel Method纳米晶SnO_2合成的溶胶-凝胶制备方法
16.Synthesis of CdS nanocrystals by a new method一种无水无氧制备CdS纳米晶的新方法
17.Preparation of Nanomether Calcium Lactate via Chemical Precipitation Method and Lamellar Liquid Crystal Method;化学沉淀法与层状液晶法制备纳米乳酸钙
18.Controlled Synthesis of Prussian Blue Analogue in Liquid-Phase;普鲁士蓝衍生物纳米晶材料的液相控制合成
相关短句/例句
lipid-based cubic liquid crystalline nanoparticle脂质立方液晶纳米粒
1.Advances in the study of lipid-based cubic liquid crystalline nanoparticles as drug delivery system;脂质立方液晶纳米粒作为药物载体的研究进展
3)Cubic nanoparticles立方晶纳米粒
1.METHODS Cubic nanoparticles were prepared through fragmentation of bulk GMO/poloxamer 407 cubic phase gel by sonication and homogenization.目的制备环孢素A立方晶纳米粒、考察其理化性质,并测定其包封率。
4)cubic nanocrystal立方状纳米晶
5)nano-liquid crystal纳米液晶
6)cuprous oxide nanocube氧化亚铜纳米立方晶
延伸阅读
多相脂质体139 , 三氨酸多相脂质体,油酸多相脂质体注射液药物名称：油酸多相脂质体注射液英文名：Polyphase Liposome-139别名： 139;多相脂质体139 , 三氨酸多相脂质体,油酸多相脂质体注射液外文名：Polyphase Liposome-139适应症： 用于治疗各种消化管癌（如胃癌、结肠癌、肝癌、胰腺癌、食管癌等）、肺癌、淋巴肉瘤、乳腺癌等。 用量用法： 开始时１日量２０ｍｌ，如无不良反应，逐渐增大剂量，最多可至１日５０ｍｌ，加入氯化钠注射液中（２５０～５００ｍｌ）混匀，缓缓静滴，滴速控制在每分钟４０～６０滴，每日１次，１个疗程总量１２００～１５００ｍｌ。如单用本品，１个疗程结束后，休息１周，进行复查，然后继续第２疗程。如是手术病人，术后２周开始维持给药，１日５０ｍｌ，每周２次，用１个月。本品亦可与化疗或放疗合用，先用本品１疗程，休息１周后，，再按常规使用化疗或放疗，可减轻化疗药物的毒副作用，提高机体免疫功能。 注意事项： 1.用前将注射液振摇均匀后与等渗盐水混匀。 2.偶有面部发热，仅需减慢滴速即能恢复正常。 3.禁用于直接静脉推注，以免危险。 4.开始用药２～３日内白细胞可能略有下降，继续给药随即回升至正常水平。 规格： 针剂：１０ｍｌ。 类别：其他抗肿瘤药及辅助治疗药
